Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Rozenbaum MH"'
Publikováno v:
In Value in Health October-November 2017 20(9):A668-A668
Publikováno v:
In Value in Health November 2016 19(7):A756-A756
Autor:
Rozenbaum MH, De Vries R, LE HH, Postma MJ, Rozenbaum, M H, De Vries, R, LE, H H, Postma, M J
Publikováno v:
Epidemiology & Infection; Aug2012, Vol. 140 Issue 8, p1503-1514, 12p
Publikováno v:
Journal of Infectious Diseases; 8/1/2011, Vol. 204 Issue 3, p377-384, 8p
Publikováno v:
Clinical Therapeutics. Aug2010, Vol. 32 Issue 8, p1517-1532. 16p.
Publikováno v:
In Value in Health 2010 13(7):A446-A446
Publikováno v:
In Value in Health 2010 13(7):A439-A439
Publikováno v:
In Value in Health 2010 13(7):A378-A378
Autor:
Perdrizet JE; Global Value and Evidence, Pfizer Canada, Kirkland, QC, Canada. Johnna.Perdrizet@pfizer.com., Rozenbaum MH; Global Value and Evidence, Pfizer B.V., Rotterdam, Netherlands., Heffler MJ; Ipsos Insight LLC, Norwalk, CT, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Sep; Vol. 13 (9), pp. 2017-2034. Date of Electronic Publication: 2024 Jul 26.
Autor:
Rozenbaum MH; Value and Evidence Team, Pneumococcal Vaccines, Pfizer Inc., Capelle a/d Ijssel, The Netherlands. mark.rozenbaum@pfizer.com., Chilson E; Pfizer Inc., Collegeville, PA, USA., Farkouh R; Pfizer Inc., Collegeville, PA, USA., Huang L; Pfizer Inc., Collegeville, PA, USA., Cane A; Pfizer Inc., Collegeville, PA, USA., Arguedas A; Pfizer Inc., Collegeville, PA, USA., Tort MJ; Pfizer Inc., Collegeville, PA, USA., Snow V; Pfizer Inc., Collegeville, PA, USA., Averin A; Avalere Health, Boston, MA, USA., Weycker D; Avalere Health, Boston, MA, USA., Hariharan D; Avalere Health, Boston, MA, USA., Atwood M; Avalere Health, Boston, MA, USA.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Apr; Vol. 13 (4), pp. 745-760. Date of Electronic Publication: 2024 Mar 16.